Design and implementation of in silico clinical trial for Bioresorbable Vascular Scaffolds.
Journal
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
ISSN: 2694-0604
Titre abrégé: Annu Int Conf IEEE Eng Med Biol Soc
Pays: United States
ID NLM: 101763872
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
entrez:
6
10
2020
pubmed:
7
10
2020
medline:
24
10
2020
Statut:
ppublish
Résumé
In the recent years, Bioresorbable Vascular Scaffolds (BVS) for the treatment of atherosclerosis have been introduced. InSilc is a cloud based in silico clinical trial (ISCT) platform for drug-eluting BVS. The platform integrates multidisciplinary and multiscale models predicting the BVS performance. In this study, we present a use case scenario and demonstrate the functioning of the individual modules and of the whole pipeline and the ability to predict BVS short, medium, long-term outcomes.
Identifiants
pubmed: 33018557
doi: 10.1109/EMBC44109.2020.9176317
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM